American Thoracic Society (ATS) 2022

Lung function trajectories in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Effect of antifibrotic therapy on survival in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Effects of nintedanib on circulating biomarkers in subjects with progressive fibrosing interstitial lung diseases (ILDs)

Safety, tolerability, and pharmacokinetics of BI 1015550 in patients with IPF

Safety, tolerability, and pharmacokinetics of BI 1015550 in healthy adult males

Safety and efficacy of BI 1015550 in patients with idiopathic pulmonary fibrosis: a Phase 2 trial